Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029523 · ClinicalTrials.gov registry record · Phase 4
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
A Phase 4 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00029523: Completed Phase 4 study, sponsored by Pacira Pharmaceuticals.
NCT00029523 is a Phase 4 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029523, a Phase 4 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used for many years to treat cancer.
Interventions
- DRUG Intrathecal (injected into the spinal fluid) DepoCyt
- DRUG Intrathecal methotrexate
- DRUG Intrathecal cytarabine (also known as ara-C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-04 |
| Est. Completion | 2004-11 |
| Phase | Phase 4 |
What the finished NCT00029523 record still lists
NCT00029523 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 3 interventions - of which Intrathecal (injected into the spinal fluid) DepoCyt is the first listed.
NCT00029523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029523 about?
NCT00029523 is a clinical study titled "DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor". The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used fo...
What is the current status of trial NCT00029523?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-04. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00029523?
The interventions under investigation include: Intrathecal (injected into the spinal fluid) DepoCyt (DRUG), Intrathecal methotrexate (DRUG), Intrathecal cytarabine (also known as ara-C) (DRUG).
Who is sponsoring clinical trial NCT00029523?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00029523's enrollment target sits among peer trials
100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia